BRCA2 and breast carcinoma: The second tested variant in our study was the BRCA2 c.1310_1313delAAGA frameshift mutation that has been reported as “pathogenic” in the ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/), the Breast Cancer Information Core (BIC) (http://www.research.nhgri.nih.gov/bic/), the HGMD (http://www.hgmd.cf.ac.uk/ac/index.php) databases.